Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dissecting Aneurysm of the Thoracic Aorta”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02919449
What this trial is testing

Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab

Who this might be right for
Recurrent Non-Small Cell Lung Cancer
Vyriad, Inc. 2
Not applicableEnded earlyNCT00981578
What this trial is testing

ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain

Who this might be right for
Bone Metastases
InSightec 37
Testing effectiveness (Phase 2)Study completedNCT00055978
What this trial is testing

Celecoxib in Preventing Lung Cancer in Former Heavy Smokers

Who this might be right for
Lung Cancer
University of California, Los Angeles 112
Not applicableStudy completedNCT07827885
What this trial is testing

20-Fr Versus 24-Fr Chest Drains After Uniportal VATS Lobectomy for NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Fondazione Policlinico Universitario Campus Bio-Medico 80
Testing effectiveness (Phase 2)Looking for participantsNCT06780085
What this trial is testing

Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 96
Not applicableStudy completedNCT05519215
What this trial is testing

ECHELON 3000 (Next Generation Powered Stapler) in General Abdominal and Thoracic Lung Resection Procedures

Who this might be right for
Laparoscopic Sleeve Gastrectomy (LSG)Thoracic Lung Resection Procedure
Ethicon Endo-Surgery 244
Testing effectiveness (Phase 2)Looking for participantsNCT06567015
What this trial is testing

Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Pierre Fabre Medicament 171
Testing effectiveness (Phase 2)Study completedNCT01327235
What this trial is testing

Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or Ascites

Who this might be right for
Malignant Pleural EffusionMalignant Ascites
Jiangsu Simcere Pharmaceutical Co., Ltd. 336
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00890825
What this trial is testing

AZD6244 in Combination With Docetaxel Versus Docetaxel Alone in KRAS Mutation Positive NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
AstraZeneca 88
Testing effectiveness (Phase 2)Study completedNCT00326599
What this trial is testing

Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 101
Large-scale testing (Phase 3)Not Yet RecruitingNCT07361484
What this trial is testing

Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4)

Who this might be right for
Non-Small Cell Lung CancerNon-squamous Non-Small Cell Lung Cance
BeyondSpring Pharmaceuticals Inc. 442
Large-scale testing (Phase 3)Looking for participantsNCT06881784
What this trial is testing

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Non-Small Cell Lung CancerNSCLC+2 more
Revolution Medicines, Inc. 590
Not applicableEnded earlyNCT01181947
What this trial is testing

VALIANT CAPTIVIA Post-market Registry

Who this might be right for
Aortic Aneurysm, Thoracic
Medtronic Cardiovascular 100
Testing effectiveness (Phase 2)Study completedNCT01853878
What this trial is testing

Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), After Removal of Their Tumor

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 137
Testing effectiveness (Phase 2)Active Not RecruitingNCT06710132
What this trial is testing

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

Who this might be right for
Solid TumorsGastric CancerNon-Small Cell Lung Cancer (NSCLC)+2 more
EMD Serono Research & Development Institute, Inc. 184
Not applicableLooking for participantsNCT06516198
What this trial is testing

Auricular Acupressure in Prehabilitation

Who this might be right for
FrailtyThoracicPrehabilitation+5 more
University of Chicago 40
Testing effectiveness (Phase 2)Ended earlyNCT00281021
What this trial is testing

Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
University of Louisville 26
Not applicableUnknownNCT05221814
What this trial is testing

Pathological Classification of Pulmonary Nodules in Images Using Deep Learning

Who this might be right for
Lung CancerArtificial Intelligence
Jiangxi Provincial Cancer Hospital 2,000
Not applicableStudy completedNCT01687738
What this trial is testing

Lung Cancer Surgery: Decisions Against Life Saving Care - The Intervention

Who this might be right for
Non-small Cell Lung Cancer
University of North Carolina, Chapel Hill 238
Next Page